HealthQuill Rheumatoid Arthritis
Johnson & Johnson has stopped a mid-trial evaluation of a combination drug to treat people with a type of arthritis after the therapy failed to show “sufficient evidence” of benefit to the patients.
Drugs Health Pharma

J & J stops rheumatoid arthritis trial due to lack of ‘sufficient evidence’

Johnson & Johnson has stopped a mid-trial evaluation of a combination drug to treat people with a type of arthritis after the therapy.

Read More
Rheumatoid arthritis may be associated with higher amounts of bacteria accumulating in the gut ten months before clinical diagnosis, researchers reveal.
Health Medical Pharma

Leed researchers find gut bacteria linked to rheumatoid arthritis

Rheumatoid arthritis may be associated with higher amounts of bacteria accumulating in the gut ten months before clinical diagnosis, researchers reveal.

Read More
The FDA has warned consumers against the use of fast-act rheum and UA-Block capsules used to treat inflammation and joint pains as it contains substances that raise blood sugar, heart attacks, and stroke.
Drugs Health Medical

Balancing gut bacteria can reduce inflammation in rheumatoid arthritis

HQ Team October 7, 2024: Rheumatoid arthritis (RA), an autoimmune disease that causes joint and bone inflammation, is affected by gut bacteria. Researchers.

Read More
Eli Lilly will license manufacturing know-how of its rheumatoid arthritis baricitinib drug, branded as Olumiant, to Egypt’s EVA Pharma to expand its access to 49 nations in Africa.
Drugs Health Pharma

Eli Lilly to license rheumatoid drug-making technology to Egypt’s EVA

Eli Lilly will license manufacturing know-how of its rheumatoid arthritis baricitinib drug, branded as Olumiant, to Egypt’s EVA Pharma to expand its access to.

Read More